Table 1.
First eye (n = 106) | Second eye (n = 103) | |||
---|---|---|---|---|
Without comorbidity (n = 78) | With comorbidity (n = 28) | Without comorbidity (n = 78) | With comorbidity (n = 25) | |
Male/Femalea | 33/45 | 15/13 | 30/48 | 9/16 |
Age (mean ± SD)b (years) | 72.6 (±8.9) | 75.0 (±8.6) | 75.2 (±9.0) | 75.3 (±6.7) |
Median nuclear opalescence (range) | 4.15 (4.00) | 4.95 (5.79) | 4.75 (4.90) | 4.55 (4.10) |
Median nuclear colour (range) | 4.05 (4.50) | 4.50 (4.50) | 4.55 (3.60) | 5.00 (4.30) |
Median cortical (range) | 2.70 (4.00) | 2.70 (5.40) | 2.85 (4.20) | 2.60 (4.00) |
Median posterior subcapsular (range) | 0.10 (4.80) | 1.55 (5.80) | 0.10 (4.40) | 0.75 (4.60) |
Abbreviations: SD = standard deviation; ANOVA = analysis of variance
aFemales and males were not equally distributed across groups (P = 0.004, Chi-square test)
bMean age was comparable across questionnaires (P > 0.05 [ANOVA])